Similarly, VLDLR gene expression was also remarkably reduced in the MS WM (*** p < 0.0001; Figure 5H), and the reduction was equally contributed when examined at a subtype-specific level (** p < 0.01 for both RRMS, SPMS, and PPMS; Figure 5H′). This evidence concerns the gene VLDLR and myeloid sarcoma.